DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: A Copper-Binding Peptide with Therapeutic Potential against Alzheimer′s Disease: From the Blood–Brain Barrier to Metal Competition

Journal Article · · ACS Chemical Neuroscience
 [1]; ORCiD logo [1]; ORCiD logo [1];  [2];  [1];  [2];  [1]; ORCiD logo [3]; ORCiD logo [4]; ORCiD logo [1];  [1]; ORCiD logo [2];  [1]; ORCiD logo [1]
  1. Center for Research and Advanced Studies (Cinvestav), Mexico City (Mexico)
  2. University of California, Santa Cruz, CA (United States)
  3. Center for Research and Advanced Studies (Cinvestav), Mexico City (Mexico); El Colegio Nacional, Mexico City (Mexico)
  4. Université Côte d′Azur, Nice (France)

Alzheimer’s disease (AD) is the most common form of dementia worldwide. AD brains are characterized by the accumulation of amyloid-β peptides (Aβ) that bind Cu2+ and have been associated with several neurotoxic mechanisms. Although the use of copper chelators to prevent the formation of Cu2+-Aβ complexes has been proposed as a therapeutic strategy, recent studies show that copper is an important neuromodulator that is essential for a neuroprotective mechanism mediated by Cu2+ binding to the cellular prion protein (PrPC). Therefore, in addition to metal selectivity and blood–brain barrier (BBB) permeability, an emerging challenge for copper chelators is to prevent the formation of neurotoxic Cu2+-Aβ species without perturbing the neuroprotective Cu2+-PrPC interaction. Previously, we reported the design of a tetrapeptide (TP) that withdraws Cu2+ from Aβ(1–16) and impacts the Cu2+-induced aggregation of Aβ(1–40). In this study, we improved the drug-like properties of TP in a BBB model, evaluated the metal selectivity of the optimized peptide (TP*), and tested its effect on Cu2+ coordination to PrPC and proteins involved in copper trafficking, such as copper transporter 1 and albumin. Our results show that changing the stereochemistry of the first residue prevents TP degradation in the BBB model and coadministration of TP with a peptide that increases BBB permeability allows its passage through the BBB model. TP* is highly selective toward Cu2+ in the presence of Zn2+ ions, transfers Cu2+ to copper-trafficking proteins, and forms a ternary TP*-Cu2+-PrP species that does not perturb the physiological conformation of PrP and displays only a minor impact in the neuroprotective Cu2+-dependent interaction of PrPC with the N-methyl-d-aspartate receptor. Overall, these results show that TP* displays desirable features for a copper chelator with therapeutic potential against AD. Moreover, this is the first study that explores the effect of a Cu2+ chelator with therapeutic potential for AD on Cu2+ coordination to PrPC (an emerging key player in AD pathology), integrating recent knowledge about metalloproteins involved in AD with the design of copper chelators against AD.

Research Organization:
Center for Research and Advanced Studies (Cinvestav), Mexico City (Mexico)
Sponsoring Organization:
National Institutes of Health (NIH); USDOE Office of Science (SC), Biological and Environmental Research (BER)
Grant/Contract Number:
AC02-76SF00515
OSTI ID:
2483936
Journal Information:
ACS Chemical Neuroscience, Journal Name: ACS Chemical Neuroscience Journal Issue: 2 Vol. 16; ISSN 1948-7193
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
English

References (92)

A Functional Role for Aβ in Metal Homeostasis? N-Truncation and High-Affinity Copper Binding journal July 2015
Resistance of Cu(Aβ416) to Copper Capture by Metallothionein‐3 Supports a Function for the Aβ442 Peptide as a Synaptic CuII Scavenger journal May 2016
A Water‐Soluble Peptoid Chelator that Can Remove Cu 2+ from Amyloid‐β Peptides and Stop the Formation of Reactive Oxygen Species Associated with Alzheimer's Disease journal October 2021
N-Terminal Cu-Binding Motifs (Xxx-Zzz-His, Xxx-His) and Their Derivatives: Chemistry, Biology and Medicinal Applications journal March 2018
Impact of N‐Truncated Aβ Peptides on Cu‐ and Cu(Aβ)‐Generated ROS: CuI Matters! journal December 2020
Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. journal November 1985
Critical Role of Tight Junctions in Drug Delivery across Epithelial and Endothelial Cell Layers journal September 2005
Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s disease journal April 2010
Prion protein expression in senile plaques in Alzheimer's disease journal January 2001
Role of N-terminal methionine residues in the redox activity of copper bound to alpha-synuclein journal July 2016
Structural implications derived from the analysis of electron paramagnetic resonance spectra of natural and artificial copper proteins journal December 1974
Copper, iron and zinc in Alzheimer's disease senile plaques journal June 1998
Ctr1 and its role in body copper homeostasis journal March 2003
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial journal September 2008
Biochemical basis of regulation of human copper-transporting ATPases journal July 2007
Drug delivery to the brain in Alzheimer's disease: Consideration of the blood–brain barrier journal May 2012
Human copper homeostasis: a network of interconnected pathways journal April 2010
Dissecting the copper bioinorganic chemistry of the functional and pathological roles of the prion protein: Relevance in Alzheimer's disease and cancer journal February 2022
Modulating the paracellular pathway at the blood–brain barrier: current and future approaches for drug delivery to the CNS journal June 2016
Designed Metal-ATCUN Derivatives: Redox- and Non-redox-Based Applications Relevant for Chemistry, Biology, and Medicine journal December 2020
Probing Copper2+ Binding to the Prion Protein Using Diamagnetic Nickel2+ and 1H NMR: The Unstructured N terminus Facilitates the Coordination of Six Copper2+ Ions at Physiological Concentrations journal March 2005
Both N-Terminal and C-Terminal Histidine Residues of the Prion Protein Are Essential for Copper Coordination and Neuroprotective Self-Regulation journal July 2020
Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with β-amyloid deposits in Alzheimer’s disease journal July 2006
Copper dyshomeostasis in Wilson disease and Alzheimer's disease as shown by serum and urine copper indicators journal January 2018
XAFS study of copper(II) complexes with square planar and square pyramidal coordination geometries journal August 2016
Metal dyshomeostasis and oxidative stress in Alzheimer’s disease journal April 2013
Aβ induces its own prion protein N-terminal fragment (PrPN1)–mediated neutralization in amorphous aggregates journal July 2014
Therapeutics for Alzheimer’s disease based on the metal hypothesis journal July 2008
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease journal April 2018
Interaction between Prion Protein's Copper-Bound Octarepeat Domain and a Charged C-Terminal Pocket Suggests a Mechanism for N-Terminal Regulation journal July 2016
Cu(II) Affinity for the Alzheimer’s Peptide: Tyrosine Fluorescence Studies Revisited journal January 2013
Amyloid β Perturbs Cu(II) Binding to the Prion Protein in a Site-Specific Manner: Insights into Its Potential Neurotoxic Mechanisms journal May 2021
Copper Exchange and Redox Activity of a Prototypical 8-Hydroxyquinoline: Implications for Therapeutic Chelation journal July 2016
Interplay between Copper, Neprilysin, and N-Truncation of β-Amyloid journal May 2018
EPR Spectroscopy Shows that the Blood Carrier Protein, Human Serum Albumin, Closely Interacts with the N-Terminal Domain of the Copper Transporter, Ctr1 journal March 2015
Molecular Features of the Copper Binding Sites in the Octarepeat Domain of the Prion Protein journal March 2002
The Affinity of Copper Binding to the Prion Protein Octarepeat Domain:  Evidence for Negative Cooperativity journal October 2006
Bioinorganic Chemistry of Parkinson’s Disease: Structural Determinants for the Copper-Mediated Amyloid Formation of Alpha-Synuclein journal October 2010
Spectroscopic and Electronic Structure Studies of Copper(II) Binding to His111 in the Human Prion Protein Fragment 106−115: Evaluating the Role of Protons and Methionine Residues journal January 2011
Mixed Ligand Cu2+Complexes of a Model Therapeutic with Alzheimer’s Amyloid-β Peptide and Monoamine Neurotransmitters journal March 2013
An understanding of the x-ray absorption near-edge structure of copper(II) imidazole complexes journal May 1990
The Octarepeat Domain of the Prion Protein Binds Cu(II) with Three Distinct Coordination Modes at pH 7.4 journal August 2005
Interaction of α-Synuclein with Divalent Metal Ions Reveals Key Differences:  A Link between Structure, Binding Specificity and Fibrillation Enhancement journal August 2006
Structural Models for Cu(II) Bound to the Fragment 92–96 of the Human Prion Protein journal January 2013
The cellular prion protein binds copper in vivo journal December 1997
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease journal May 2013
Copper(II)-binding equilibria in human blood journal March 2020
Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-β peptide journal January 2009
A bifunctional non-natural tetrapeptide modulates amyloid-beta peptide aggregation in the presence of Cu(ii) journal January 2014
The N-terminal 14-mer model peptide of human Ctr1 can collect Cu(ii) from albumin. Implications for copper uptake by Ctr1 journal January 2018
Development of Cu(ii)-specific peptide shuttles capable of preventing Cu–amyloid beta toxicity and importing bioavailable Cu into cells journal January 2022
EPR spectroscopic characterisation of native CuII-binding sites in human serum albumin journal January 2024
Immunogold labeling and X-ray fluorescence microscopy reveal enrichment ratios of Cu and Zn, metabolism of APP and amyloid-β plaque formation in a mouse model of Alzheimer's disease journal January 2012
Copper accumulation and the effect of chelation treatment on cerebral amyloid angiopathy compared to parenchymal amyloid plaques journal January 2020
Regulation of spine morphology and spine density by NMDA receptor signaling in vivo journal December 2007
Aβ neurotoxicity depends on interactions between copper ions, prion protein, and N -methyl- d -aspartate receptors journal January 2012
Evidence for aggregation-independent, PrP C -mediated Aβ cellular internalization journal November 2020
Amyloid plaque core protein in Alzheimer disease and Down syndrome. journal June 1985
Copper binding to the prion protein: Structural implications of four identical cooperative binding sites journal March 1999
Deconvoluting the Cu2+ Binding Modes of Full-length Prion Protein journal January 2008
Copper signaling in the brain and beyond journal October 2017
The essential elements of Alzheimer’s disease journal January 2021
Prion Protein and Copper Cooperatively Protect Neurons by Modulating NMDA Receptor Through S-nitrosylation journal March 2015
High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer’s disease journal February 2014
Copper-mediated β-amyloid toxicity and its chelation therapy in Alzheimer's disease journal March 2022
Neuronal signalling of zinc: from detection and modulation to function journal September 2022
Nanostructure and dynamics of N-truncated copper amyloid-β peptides from advanced X-ray absorption fine structure journal April 2024
Accumulation of cellular prion protein within β‐amyloid oligomer plaques in aged human brains journal February 2021
Accumulation of cellular prion protein within dystrophic neurites of amyloid plaques in the Alzheimer's disease brain journal November 2010
Glutamate Receptor Ion Channels: Structure, Regulation, and Function journal August 2010
The prion principle and Alzheimer’s disease journal September 2024
Copper and the Prion Protein: Methods, Structures, Function, and Disease journal May 2007
A practical guide to evaluating colocalization in biological microscopy journal April 2011
Zinc Metalloproteinases and Amyloid Beta-Peptide Metabolism: The Positive Side of Proteolysis in Alzheimer's Disease journal January 2011
Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation journal January 2012
The neuropathological diagnosis of Alzheimer’s disease journal August 2019
Mutation of copper binding sites on cellular prion protein abolishes its inhibitory action on NMDA receptors in mouse hippocampal neurons journal July 2021
The rotavirus surface protein VP8 modulates the gate and fence function of tight junctions in epithelial cells journal November 2004
Transmigration of Neural Stem Cells across the Blood Brain Barrier Induced by Glioma Cells journal April 2013
Evidence of Presynaptic Location and Function of the Prion Protein journal October 1999
Strategies that Target Tight Junctions for Enhanced Drug Delivery journal November 2016
Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability journal October 2018
Elevated copper in the amyloid plaques and iron in the cortex are observed in mouse models of Alzheimer's disease that exhibit neurodegeneration journal January 2013
PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses journal April 2010
Role of Copper in the Onset of Alzheimer’s Disease Compared to Other Metals journal January 2018
The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease journal June 2017
Structure and Synaptic Function of Metal Binding to the Amyloid Precursor Protein and its Proteolytic Fragments journal January 2017
Zinc Signal in Brain Diseases journal November 2017
Non-Ceruloplasmin Copper Identifies a Subtype of Alzheimer’s Disease (CuAD): Characterization of the Cognitive Profile and Case of a CuAD Patient Carrying an RGS7 Stop-Loss Variant journal March 2023
Chelator PBT2 Forms a Ternary Cu2+ Complex with β-Amyloid That Has High Stability but Low Specificity journal May 2023
Mechanism of Cu entry into the brain: many unanswered questions journal January 2024
The cellular prion protein and its role in Alzheimer disease journal April 2009